Home
Mail
News
Sport
Finance
Celebrity
Style
Weather
Mobile
Messenger
Movies
More
Yahoo
Mail
News
Market Data
Crypto
Bank of England
Money Matters
Property
Top Stocks
Work & Management
Industry News
Brexit
My Portfolio
My Screeners
Watchlists
Videos
UK markets closed
FTSE 100
8,285.71
+99.36
(+1.21%)
FTSE 250
21,356.30
+471.95
(+2.26%)
AIM
779.67
+6.64
(+0.86%)
GBP/EUR
1.1844
-0.0006
(-0.05%)
GBP/USD
1.2873
+0.0019
(+0.14%)
Bitcoin GBP
52,964.71
+663.62
(+1.27%)
PROPERTY
8 champion homes in Olympic host cities
A selection of properties in former Games cities as Paris 2024 starts
Kiromic BioPharma, Inc. (KRBP)
OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
1.7900
0.0000
(0.00%)
At close: 04:00PM EDT
Summary
Chart
Conversations
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
10,572
9,625
13,920
11,368
5,053
-
Selling general and administrative
9,703
10,314
17,194
13,938
14,144
-
Total operating expenses
20,275
19,939
31,114
25,306
19,197
-
Operating income or loss
-20,275
-19,939
-31,114
-25,306
-19,197
-
Interest expense
2,479
1,852
166.5
12.2
3.3
-
Total other income/expenses net
-
842.2
-3,450
-270.8
-
-
Income before tax
-21,797
-20,949
-34,731
-25,589
-19,200
-
Income tax expense
-
-
-
-
-
0
Income from continuing operations
-21,797
-20,949
-34,731
-25,589
-19,200
-
Net income
-21,797
-20,949
-34,731
-25,589
-19,200
-
Net income available to common shareholders
-25,237
-23,499
-35,076
-25,811
-19,913
-
Basic EPS
-19.51
-12.59
-64.42
-67.81
-132.60
-
Diluted EPS
-19.51
-12.59
-64.42
-67.81
-132.60
-
Basic average shares
932.02
1,098
544.475
380.607
150.195
-
Diluted average shares
932.02
1,098
544.475
380.607
150.195
-
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.